{"id":"https://openalex.org/W7141008599","doi":"https://doi.org/10.64898/2026.03.25.713450","title":"KyDab \u2013 a comprehensive database of antibody discovery selection campaigns","display_name":"KyDab \u2013 a comprehensive database of antibody discovery selection campaigns","publication_year":2026,"publication_date":"2026-03-27","ids":{"openalex":"https://openalex.org/W7141008599","doi":"https://doi.org/10.64898/2026.03.25.713450"},"language":"en","primary_location":{"id":"doi:10.64898/2026.03.25.713450","doi":"https://doi.org/10.64898/2026.03.25.713450","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.03.25.713450","pdf_url":null,"source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.64898/2026.03.25.713450","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029413593","display_name":"Qingqing Zhou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210144642","display_name":"Kymab (United Kingdom)","ror":"https://ror.org/04y4x5p83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210144642"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Qingqing Zhou","raw_affiliation_strings":["Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I4210144642"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092422087","display_name":"Dawid Chomicz","orcid":"https://orcid.org/0009-0000-7943-6082","observed_orcids":["https://orcid.org/0009-0000-7943-6082"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dawid Chomicz","raw_affiliation_strings":["R&D, NaturalAntibody, Szczecin, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R&D, NaturalAntibody, Szczecin, Poland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005272450","display_name":"David G. Melvin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210144642","display_name":"Kymab (United Kingdom)","ror":"https://ror.org/04y4x5p83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210144642"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David Melvin","raw_affiliation_strings":["Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I4210144642"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5130781331","display_name":"Mark Griffiths","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210144642","display_name":"Kymab (United Kingdom)","ror":"https://ror.org/04y4x5p83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210144642"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mark Griffiths","raw_affiliation_strings":["Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I4210144642"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070621788","display_name":"Sabrina Yahiya","orcid":"https://orcid.org/0000-0003-1600-6186","observed_orcids":["https://orcid.org/0000-0003-1600-6186"]},"institutions":[{"id":"https://openalex.org/I4210144642","display_name":"Kymab (United Kingdom)","ror":"https://ror.org/04y4x5p83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210144642"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sabrina Yahiya","raw_affiliation_strings":["Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I4210144642"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068981667","display_name":"Stephen T. Reece","orcid":"https://orcid.org/0000-0003-0725-6271","observed_orcids":["https://orcid.org/0000-0003-0725-6271"]},"institutions":[{"id":"https://openalex.org/I4210144642","display_name":"Kymab (United Kingdom)","ror":"https://ror.org/04y4x5p83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210144642"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Stephen T. Reece","raw_affiliation_strings":["Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I4210144642"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050730834","display_name":"Marguerite-Marie Le Pann\u00e9rer","orcid":"https://orcid.org/0000-0002-5779-8805","observed_orcids":["https://orcid.org/0000-0002-5779-8805"]},"institutions":[{"id":"https://openalex.org/I4210144642","display_name":"Kymab (United Kingdom)","ror":"https://ror.org/04y4x5p83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210144642"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Marguerite-Marie Le Pannerer","raw_affiliation_strings":["Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I4210144642"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015244397","display_name":"Konrad Krawczyk","orcid":"https://orcid.org/0000-0003-0697-5522","observed_orcids":["https://orcid.org/0000-0003-0697-5522"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Konrad Krawczyk","raw_affiliation_strings":["R&D, NaturalAntibody, Szczecin, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R&D, NaturalAntibody, Szczecin, Poland","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5015244397"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibody-discovery","display_name":"antibody discovery","score":0.9359999895095825},{"id":"https://openalex.org/keywords/immune-repertoire","display_name":"immune repertoire","score":0.6019999980926514},{"id":"https://openalex.org/keywords/antibody-binding","display_name":"antibody binding","score":0.5429999828338623},{"id":"https://openalex.org/keywords/immunization","display_name":"immunization","score":0.4000000059604645},{"id":"https://openalex.org/keywords/antibody-database","display_name":"antibody database","score":0.43700000643730164}],"concepts":[{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.6139000058174133},{"id":"https://openalex.org/C177212765","wikidata":"https://www.wikidata.org/wiki/Q627335","display_name":"Workflow","level":2,"score":0.5884000062942505},{"id":"https://openalex.org/C81917197","wikidata":"https://www.wikidata.org/wiki/Q628760","display_name":"Selection (genetic algorithm)","level":2,"score":0.5156999826431274},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4611000120639801},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4449000060558319},{"id":"https://openalex.org/C124101348","wikidata":"https://www.wikidata.org/wiki/Q172491","display_name":"Data mining","level":1,"score":0.4390999972820282},{"id":"https://openalex.org/C93518851","wikidata":"https://www.wikidata.org/wiki/Q180160","display_name":"Metadata","level":2,"score":0.42829999327659607},{"id":"https://openalex.org/C77088390","wikidata":"https://www.wikidata.org/wiki/Q8513","display_name":"Database","level":1,"score":0.4226999878883362},{"id":"https://openalex.org/C120567893","wikidata":"https://www.wikidata.org/wiki/Q1582085","display_name":"Knowledge extraction","level":2,"score":0.3817000091075897},{"id":"https://openalex.org/C98045186","wikidata":"https://www.wikidata.org/wiki/Q205663","display_name":"Process (computing)","level":2,"score":0.3495999872684479},{"id":"https://openalex.org/C206345919","wikidata":"https://www.wikidata.org/wiki/Q20380951","display_name":"Resource (disambiguation)","level":2,"score":0.3434999883174896},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.3303999900817871},{"id":"https://openalex.org/C2910693471","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody Repertoire","level":3,"score":0.3197999894618988},{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.29670000076293945},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.2651999890804291},{"id":"https://openalex.org/C23123220","wikidata":"https://www.wikidata.org/wiki/Q816826","display_name":"Information retrieval","level":1,"score":0.2578999996185303},{"id":"https://openalex.org/C119857082","wikidata":"https://www.wikidata.org/wiki/Q2539","display_name":"Machine learning","level":1,"score":0.2502000033855438}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.64898/2026.03.25.713450","doi":"https://doi.org/10.64898/2026.03.25.713450","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.03.25.713450","pdf_url":null,"source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.64898/2026.03.25.713450","doi":"https://doi.org/10.64898/2026.03.25.713450","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.03.25.713450","pdf_url":null,"source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.504800021648407,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1030883578","https://openalex.org/W2110505462","https://openalex.org/W2140674483","https://openalex.org/W2151558930","https://openalex.org/W2283896596","https://openalex.org/W2950118240","https://openalex.org/W2974982237","https://openalex.org/W3171867063","https://openalex.org/W4361003666","https://openalex.org/W4388735138","https://openalex.org/W4399868154","https://openalex.org/W4405409734","https://openalex.org/W4405529826","https://openalex.org/W4409321052","https://openalex.org/W4411779612","https://openalex.org/W4413037210","https://openalex.org/W4414743051","https://openalex.org/W4414948154"],"related_works":["https://openalex.org/W7167654421","https://openalex.org/W7167648648","https://openalex.org/W6894299474","https://openalex.org/W7208561133","https://openalex.org/W4388735138","https://openalex.org/W7167646993","https://openalex.org/W6891405770","https://openalex.org/W3139923728","https://openalex.org/W7222450172","https://openalex.org/W4405610228"],"abstract_inverted_index":{"Abstract":[0],"Preclinical":[1],"antibody":[2,39,115],"discovery":[3,40],"relies":[4],"on":[5,47],"progressive":[6],"screening":[7],"and":[8,73,92,95,108,123],"down-selection":[9],"of":[10,38,80,110],"candidate":[11],"antibodies":[12],"from":[13],"large":[14],"immune":[15],"repertoires,":[16],"yet":[17],"this":[18],"critical":[19],"process":[20],"is":[21,118],"poorly":[22],"represented":[23],"in":[24],"existing":[25],"public":[26],"databases.":[27],"Here":[28],"we":[29],"introduce":[30],"KyDab":[31,99,117],"(Kymouse":[32],"Antibody":[33],"Database),":[34],"a":[35,77,101],"well-curated":[36],"database":[37,125],"selection":[41,87],"data":[42,88,103],"generated":[43],"using":[44],"standardized":[45],"workflows":[46],"the":[48,106,124],"Kymouse":[49,58],"humanized":[50],"mouse":[51],"platform.":[52],"The":[53],"current":[54],"release":[55],"includes":[56],"11":[57],"platform":[59],"mice":[60],"immunisation":[61],"studies":[62],"covering":[63],"51":[64],"immunogens,":[65],"more":[66],"than":[67],"120,000":[68],"paired":[69],"heavy\u2013light":[70],"chain":[71],"sequences,":[72],"binding":[74],"measurements":[75],"for":[76,105,114],"selected":[78],"subset":[79],"experimentally":[81],"characterized":[82],"clones.":[83],"By":[84],"capturing":[85],"full-funnel":[86],"with":[89],"consistent":[90],"metadata":[91],"both":[93],"positive":[94],"negative":[96],"experimental":[97],"outcomes,":[98],"provides":[100],"valuable":[102],"resource":[104],"development":[107],"evaluation":[109],"artificial":[111],"intelligence":[112],"models":[113],"discovery.":[116],"accessible":[119],"at":[120],"https://kydab.naturalantibody.com/":[121],",":[122],"will":[126],"be":[127],"continuously":[128],"updated":[129],"as":[130],"new":[131],"datasets":[132],"become":[133],"available.":[134]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-03-28T00:00:00"}